HSV-1, or herpes simplex virus type 1, is a common virus that causes cold sores on or around the mouth. An estimated 3.8 billion people under age 50, roughly 64% of the global population, carry the infection. Most people pick it up during childhood through everyday contact like a kiss from a family member, and many never develop noticeable symptoms.
How HSV-1 Differs From HSV-2
Both HSV-1 and HSV-2 belong to the same virus family and genus. They cause similar-looking blisters, but they tend to prefer different parts of the body. HSV-1 is the main cause of oral herpes (cold sores), while HSV-2 is more closely associated with genital herpes. That said, HSV-1 can infect the genitals too, typically through oral sex, and it’s now a growing cause of genital herpes in many countries.
Genetically, HSV-1 shows more diversity across its strains than HSV-2 does. Researchers have even found natural recombinants of the two viruses in clinical samples, meaning the two types can swap genetic material in people infected with both.
How It Spreads
HSV-1 spreads through direct contact with the virus, most commonly through saliva or skin-to-skin contact around the mouth. You can get it from kissing someone with oral herpes, sharing utensils or lip products, or receiving oral sex from an infected partner. The virus can also travel from the mouth to a partner’s genitals during oral sex, which is how genital HSV-1 infections typically occur.
One of the reasons HSV-1 is so widespread is that the skin can release (or “shed”) the virus even when no sore is visible. A person may have no idea they’re contagious. Shedding happens intermittently and unpredictably, which makes the virus difficult to avoid entirely in close relationships.
Symptoms and What an Outbreak Feels Like
Many people with HSV-1 never notice symptoms at all. When symptoms do appear, they usually show up as small, fluid-filled blisters on or around the lips, sometimes called cold sores or fever blisters. Before the blisters form, you may feel tingling, itching, or burning in that spot. The blisters eventually break open, crust over, and heal within one to two weeks.
The first outbreak tends to be the most severe. You might experience swollen lymph nodes, fever, or body aches along with the sores. Recurrent outbreaks are usually milder and shorter, and for many people they become less frequent over time. Some people have one or two outbreaks a year; others go years without one.
When HSV-1 infects the genitals, the sores look similar but appear on or around the genital area. Genital HSV-1 tends to recur less often than genital HSV-2, which can be reassuring for people who receive that diagnosis.
What Triggers a Recurrence
After the initial infection, HSV-1 doesn’t leave the body. It retreats into nerve cells near the base of the skull and stays dormant there, sometimes for months or years. Certain triggers can wake the virus up, sending it back along the nerve to the skin surface where it causes a new outbreak.
Researchers at the University of Virginia found the underlying mechanism: when neurons harboring the virus become overexcited, HSV senses that change and reactivates. The immune system releases a signaling molecule called interleukin-1 beta during prolonged stress or inflammation. That same molecule is released by skin cells damaged by ultraviolet light. It increases excitability in the affected neurons, creating the conditions for a flare-up.
This explains why the classic triggers are so consistent: emotional stress, illness or fever, sun exposure, fatigue, hormonal changes (like menstruation), and physical trauma to the lips or face. Knowing your personal triggers can help you anticipate and sometimes prevent outbreaks.
How HSV-1 Is Diagnosed
If you have an active sore, a healthcare provider can often recognize it on sight. The most reliable test involves swabbing fluid from a blister that hasn’t yet crusted over. That sample is analyzed using a molecular test that detects the virus’s genetic material and can distinguish between HSV-1 and HSV-2.
Blood tests look for antibodies your immune system produces in response to the virus. These tests can confirm a past infection even when no sores are present, but they have a significant limitation: after exposure, it can take up to 16 weeks or more for current blood tests to detect infection. A negative blood test soon after a suspected exposure doesn’t necessarily rule HSV-1 out. Routine screening for herpes in people without symptoms is not standard practice in most healthcare settings, partly because of these testing limitations and partly because of the high rate of infection in the general population.
Treatment and Managing Outbreaks
There is no cure for HSV-1, but antiviral medications can shorten outbreaks and reduce their frequency. For a first episode, treatment typically runs 7 to 10 days and can be extended if sores haven’t fully healed. Recurrent episodes are shorter and often respond to a briefer course of the same medications, especially if started at the first sign of tingling.
For people who experience frequent outbreaks, daily suppressive therapy is an option. Taking an antiviral every day reduces the frequency of recurrences by 70% to 80%. Long-term daily use has a well-documented safety record. Many people with infrequent or mild outbreaks choose not to take daily medication and instead keep a prescription on hand to use at the first sign of a flare.
Beyond medication, keeping the affected area clean and dry during an outbreak helps sores heal. Over-the-counter pain relievers and topical numbing agents can ease discomfort. Avoiding known triggers, wearing lip balm with SPF in the sun, and managing stress can all reduce how often outbreaks occur.
Rare but Serious Complications
For most people, HSV-1 is a manageable nuisance. In certain situations, however, it can cause serious harm.
HSV-1 can infect the eye, leading to a condition that causes pain, light sensitivity, and blurred vision. Repeated episodes can scar the cornea, and it remains one of the leading infectious causes of blindness in developed countries. In very rare cases, the virus can infect the brain, causing inflammation that requires emergency treatment.
Neonatal herpes is the most concerning complication. In about 85% of cases, the virus passes from mother to baby during delivery when the virus is present in the genital tract. Symptoms in newborns, which usually appear 10 to 12 days after birth, can include fluid-filled blisters on the skin, unstable body temperature, irritability, and seizures. The infection can spread to the baby’s brain, liver, and lungs, making it potentially life-threatening. People with genital herpes who are pregnant should discuss their history with their obstetric provider so precautions can be taken before delivery.
Vaccines and the Current Outlook
No approved vaccine exists for either type of herpes simplex virus. Several candidates are in early-stage human trials. One notable effort, developed by BioNTech using the same RNA platform behind their COVID-19 vaccine, is currently in Phase 1 trials evaluating safety and immune response. It primarily targets HSV-2 genital lesions but may also offer protection against HSV-1. Multiple other approaches are in development, but a commercially available vaccine is still years away at best.
Living with HSV-1 is extremely common, and for most people the virus has a minimal impact on daily life. Understanding how it spreads, what triggers it, and what treatment options exist puts you in a strong position to manage it effectively.